Huons Global Co Ltd - Company Profile

Powered by

All the sales intelligence you need on Huons Global Co Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Huons Global Co Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Huons Global Co Ltd.

Back to companies

Huons Global Co Ltd: Segment Analysis

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Business Description

Huons Global Co Ltd (Huons) develops, manufactures, and markets a wide range of pharmaceutical and healthcare products across multiple sectors. The company focuses on pharmaceuticals, biopharmaceutical research and development, aesthetics, medical devices, and health food. It generates income through trademark licensing fees, management consulting fees, dividends, and rental income.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

The company's R&D activities focus on expanding its total healthcare portfolio and enhancing global competitiveness through sustained investment and subsidiary-driven innovation. The company, together with its affiliates like Huonslab and PanGen Biotech, is advancing innovative therapeutics and platform technologies. The main priorities consist of biologics and drug-delivery innovations, specifically the human hyaluronidase programs, for instance, Hydizyme/HLB3-002, which is designed to simplify the subcutaneous administration of antibodies and additional drugs. The pipeline also targets high unmet medical needs, including Alzheimer’s disease, obesity, and diabetes, while improving established products in areas such as eye care and aesthetics. The company further strengthens capabilities in botulinum toxin development and supports growth in health supplements and functional foods through ingredient-based innovation. To accelerate development and commercialization, Huons integrates R&D and production across subsidiaries and actively pursues global regulatory approvals example, FDA/EMA for key pipeline assets. In FY2024, the company spent KRW65,758.3 million on its R&D activities, which as a percentage of revenue stood at 8.1% and grew 10.4% YoY.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer